Last reviewed: June 9, 2026

Last updated: June 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists have transformed weight management and diabetes care, with clinical trials showing an average weight loss of 15–22% in patients using these medications. Understanding how GLP-1 works, who benefits most, and which formulation suits your health goals can help you make an informed decision about this evidence-based treatment approach.

How Does GLP-1 Work in Your Body?

GLP-1 is a natural hormone your gut produces when you eat, signaling your pancreas to release insulin and telling your brain you feel full. GLP-1 receptor agonist medications replicate this hormone's action, slowing how quickly your stomach empties and reducing hunger signals sent to your brain. This dual mechanism addresses both appetite control and blood sugar regulation, making GLP-1 therapy effective for weight loss and type 2 diabetes management.

The medication binds to specific receptors throughout your body—primarily in the pancreas, stomach, and brain—triggering a cascade of metabolic changes. These changes include improved insulin secretion when blood sugar rises, decreased glucagon release when it shouldn't spike, and enhanced satiety that naturally leads to eating less. Research shows that GLP-1 agonists also improve how your body handles fat and may increase energy expenditure at rest.

GLP-1 vs. Tirzepatide: Understanding Your Treatment Options

Semaglutide is a GLP-1 receptor agonist that targets one hormone pathway, making it a proven first-line option for weight loss and diabetes control. Tirzepatide, by contrast, is a GIP/GLP-1 receptor agonist that activates two pathways simultaneously, offering slightly faster weight loss in clinical studies. PlexusDx offers both as compounded injections and oral formulations, allowing you to choose the delivery method and potency level that fits your lifestyle.

Your genetics may influence which medication works better for your body. The Precision Peptide Genetic Test available at PlexusDx examines key variants like GLP1R rs6923761 and GIPR rs1800437 to map your peptide pathways and predict medication response. Knowing your genetic profile helps PlexusDx clinicians recommend semaglutide, tirzepatide, or even a dual-compound GLP-Squared formula tailored to your physiology.

What Does Clinical Evidence Show About GLP-1 Weight Loss?

The NOVO NORDISK SELECT trial and similar large-scale studies demonstrated that semaglutide users lost an average of 15–17% of body weight over 68 weeks, compared to 2–3% in placebo groups. Tirzepatide trials showed even more substantial results, with patients losing up to 22% of body weight when used as prescribed. These outcomes have been consistent across diverse populations and maintained when patients continue treatment.

Beyond weight loss, GLP-1 medications improve cardiovascular health markers including blood pressure, cholesterol levels, and inflammatory markers. Patients often experience better blood sugar control, reduced appetite-related emotional eating, and improved energy levels within 2–4 weeks of starting therapy. Clinical evidence also supports sustained weight maintenance when patients remain on their prescribed regimen, though weight regain can occur if treatment is discontinued.

Why Choose PlexusDx for GLP-1 Therapy?

PlexusDx compounds all semaglutide and tirzepatide medications through licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality without relying on brand-name markups. Treatment starts at $149 per month for compounded semaglutide injection, with HSA and FSA eligibility, no insurance requirement, and availability across all 50 states. Your dose may need to go up as you progress through your weight loss journey, but your price won't—making this an affordable, transparent option.

PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after your first month) to map your response across 14 peptide pathways, 49 peptides, and 150+ genetic insights tied to weight loss success. This personalized approach means your clinician can recommend the optimal medication, starting dose, and escalation schedule based on your unique biology—not guesswork. The combination of compounded quality, fixed pricing, and genetic precision gives you confidence in your treatment plan.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Who is a good candidate for GLP-1 therapy?

GLP-1 medications are appropriate for individuals with a BMI ≥27 with weight-related health conditions, or ≥30 regardless of comorbidity, as well as anyone with type 2 diabetes. PlexusDx clinicians assess your medical history, current medications, and metabolic markers to confirm candidacy and recommend the best formulation for your needs.

How quickly will I see weight loss results?

Most patients notice reduced hunger and appetite within 1–2 weeks of starting GLP-1 therapy. Measurable weight loss typically appears within 4–6 weeks as your calorie intake decreases naturally. Progressive weight loss continues over 12–16 weeks as your dose is optimized, with the majority of results occurring in the first 6 months.

What is the cost of GLP-1 treatment at PlexusDx?

PlexusDx compounded semaglutide injection starts at $149 per month, oral semaglutide at $249 per month, and tirzepatide injection at $249 per month—with no insurance needed and HSA/FSA eligibility. Your dose may increase, but your monthly price stays the same, making long-term treatment predictable and affordable across all 50 states.

Are there side effects with GLP-1 medications?

Common mild side effects include nausea, constipation, and decreased appetite—most resolve within 1–3 weeks as your body adjusts. Serious side effects are rare but can include pancreatitis or severe allergic reactions; discontinue and seek immediate care if you experience severe abdominal pain. PlexusDx clinicians monitor your progress and adjust dosing to minimize side effects while maximizing weight loss.

How does the Precision Peptide Genetic Test improve my results?

The Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R genes to reveal how your body processes GLP-1 pathways and responds to weight loss interventions. This information allows PlexusDx clinicians to predict whether semaglutide, tirzepatide, or a dual-compound option will work best for your genetics, increasing the likelihood of optimal weight loss outcomes.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves